Method Article

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

DOI:

10.3791/57664

June 13th, 2018

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Here, we present a protocol for the generation of induced pluripotent Stem Cells (iPSCs) from Li-Fraumeni Syndrome (LFS) patient derived fibroblasts, differentiation of iPSCs via mesenchymal stem cells (MSCs) to osteoblasts, and modeling in vivo tumorigenesis using LFS patient-derived osteoblasts.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Li-Fraumeni syndrome (LFS) is an autosomal dominant hereditary cancer disorder. Patients with LFS are predisposed to a various type of tumors, including osteosarcoma--one of the most frequent primary non-hematologic malignancies in the childhood and adolescence. Therefore, LFS provides an ideal model to study this malignancy. Taking advantage of iPSC methodologies, LFS-associated osteosarcoma can be successfully modeled by differentiating LFS patient iPSCs to mesenchymal stem cells (MSCs), and then to osteoblasts--the cells of origin for osteosarcomas. These LFS osteoblasts recapitulate oncogenic properties of osteosarcoma, providing an attractive model system for delineating the pathogenesis of osteosarcoma. This manuscript demonstrates a protocol for the generation of iPSCs from LFS patient fibroblasts, differentiation of iPSCs to MSCs, differentiation of MSCs to osteoblasts, and in vivo tumorigenesis using LFS osteoblasts. This iPSC disease model can be extended to identify potential biomarkers or therapeutic targets for LFS-associated osteosarcoma.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Between 2006 and 2007, several breakthrough findings from the laboratories of Drs. Shinya Yamanaka and James A. Thomson led to the development of induced pluripotent stem cells (iPSCs)1,2,3. By reprogramming somatic cells with defined transcriptional factors to form iPSCs, researchers were able to generate cells with key characteristics namely, pluripotency, and self-renewal, which was previously thought to only exist in human embryonic stem cells (hESCs). iPSCs could be generated from any individual or patient and did not have to be derived from embryos, vastly expanding the....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was approved by The University of Texas Health Science Center at Houston (UTHealth) Animal Welfare Committee. The experiments are performed in strict accordance with the standards established by the UTHealth Center for Laboratory Animal Medicine & Care (CLAMC) which is accredited by American Association for Laboratory Animal Care (AAALAC International).The human subjects in this study fall under Scenario A ("No Human Subjects Research") as defined by the NIH SF424 documentation. Therefore, it does not need any approval by UTHealth human research ethics committee.

1. Generation of LFS iPSCs (Figure 1A....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol presents the procedures including LFS iPSC generation, MSC differentiation, osteoblast differentiation, and in vivo tumorigenesis assay using LFS MSC-derived osteoblasts.

Scheme for the generation of LFS iPSCs from fibroblasts by using a commercially available Sendai virus reprogramming kit is shown in Figure 1A. Sendai virus-based delivery of the Yamanaka four factors is a no.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

To achieve higher MSC differentiation efficiency, several aspects are critical. One is the culture condition of iPSCs before initiating MSC differentiation. The protocol presented in the manuscript is based on previous studies 9,17. iPSCs need to be cultured on MEFs for at least 2 weeks. Maintaining iPSCs in good conditions on MEFs are critical for cells to attach on the gelatin-coated plate for MSC differentiation. Another important aspect is the density of iPSC.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

R. Z. is supported by UTHealth Innovation for Cancer Prevention Research Training Program Pre-Doctoral Fellowship (Cancer Prevention and Research Institute of Texas grant RP160015). J.T. is supported by the Ke Lin Program of the First Affiliated Hospital of Sun Yat-sen University. D.-F.L. is the CPRIT scholar in Cancer Research and supported by NIH Pathway to Independence Award R00 CA181496 and CPRIT Award RR160019.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Plastic ware
100 mm DishCorning430107
60 mm DishCorning430166
6-well PlateFalcon353046
12-well PlateFalcon353043
48-well PlateFalcon353078
1 mL Pipet TipUSA Scientific1111-2721
200 µL Pipet TipUSA Scientific1111-0706
10 µL Pipet TipUSA Scientific1111-3700
5 mL Serological PipetteSARSTEDT86.1253.001
10 mL Serological PipetteSARSTEDT86.1254.001
25 mL Serological PipetteSARSTEDT86.1685.001
50 mL Tube, PPSARSTEDT62.547.100
15 mL Tube, PPSARSTEDT62.554.100
Culture materials and Reagents
CytoTune- iPS 2.0 Sendai Reprogramming KitInvitrogenA16517Commercial Sendai virus reprogramming kit
Corning hESC-Qualified MatrixCorning354277Basement membrane matrix
CF1 MEFs, irradiatedThermoFisherA34180
DMEMSigma-AldrichD5671
DMEM/F12Corning10-090-CV
αMEMCorning10-022-CV
StemMACS iPS-Brew XFMiltenyi Biotec130-104-368Commercial iPSC medium
KnockOut DMEM/F-12ThermoFisher12660012
FBS Opti-GoldGenDEPOTF0900-050
KnockOut Serum ReplacementThermoFisherA3181502
Penicillin-StreptomycinSigma-AldrichP4333
MEM Nonessential Amino AcidsCorning25-025-CI
L-Glutamine SolutionSigma-AldrichG7513
2-MercaptoethanolSigma-AldrichM3148
Human FGF-basic (bFGF)PEPROTECH100-18B
Recombinant Human PDGF-ABPEPROTECH100-00AB
β-GlycerophosphateSigma-AldrichG9422
DexamethasoneSigma-AldrichA4902
Ascorbic AcidSigma-AldrichA5960
Dulbecco's Phosphate-Buffered Saline, 1x (DPBS)Corning21-031-CV
StemMACS Passaging Solution XFMiltenyi Biotec130-104-688Commercial passaging solution
Accutatse Cell Detachment SolutionCorning25-058-CICell detachment solution
Thiazovivin (ROCK Inhibitor)Calbiochem420220
0.25% Trypsin-EDTA SolutionSigma-AldrichT4049
Collagenase, Type II  ThermoFisher17101015
Human NANOG AntibodyR&D SystemAF1997
OCT4 Antibody (H-134)Santa Cruzsc-9081
Human/Mouse SSEA-4 PE-conjugated AntibodyR&D SystemFAB1435P
Alexa Fluor 555 Mouse Anti-Human TRA-1-81 AntigenDB Biosciences560123
Alexa Fluor 488 Donkey Anti-Goat IgG (H+L)Jackson ImmunoResearch705-545-003
Alexa Fluor 488 Goat Anti-Rabbit IgG (H+L)Jackson ImmunoResearch111-545-144
PE Mouse Anti-Human CD105eBioscience12-1057-42
FITC Mouse Anti-Human CD44DB Biosciences555478
PE Mouse Anti-Human CD73DB Biosciences550257
PE Mouse Anti-Human CD166DB Biosciences560903
FITC Mouse Anti-Human CD24DB Biosciences555427
Donkey SerumJackson ImmunoResearch017-000-121
Goat SerumJackson ImmunoResearch005-000-121
Alkaline Phosphatase Staining Kit IIStemgent00-0055
Alizarin Red SSigma-AldrichA5533
TRIzol ReagentThermoFisher15596018
ChloroformThermoFisherC298-500
2-PropanolThermoFisherA416-4
Ethanol, Absolute, Molecular Biology GradeThermoFisherBP28184
DNase I, RNase-free (1 U/µL)ThermoFisherEN0521
iScript cDNA Synthesis KitBioRad1708891BUN
iQ SYBR Green SupermixBioRad1708884
Matrigel Matrix High Concentration (HC), Phenol-Red FreeCorning354262
1 mL Slip Tip Syringe, 26 Gauge x 5/8 InchDB Biosciences309597

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126 (4), 663-676 (2006).
  2. Takahashi, K., et al. Induction of pluripotent stem cells from adult h....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Li Fraumeni SyndromeiPSC DifferentiationMesenchymal Stem CellsOsteoblast DifferentiationIn Vivo TumorigenesisAlkaline Phosphatase StainingAlizarin Red S StainingImmunofluorescent StainingSubcutaneous InjectionNude Mouse Model

Related Articles